";s:4:"text";s:3945:"In the event the antibiotic is implicated as the causative factor for the deterioration, it may be necessary to discontinue the treatment and begin a non-neurotoxic antibiotic.Certain classes of antibiotics have been associated with aggravating or unmasking MG and should ideally be avoided in patients with the condition.
In addition, questionable temporal relationships or other confounding factors sometimes make interpretation of the case reports difficult. In 2011 the US Food and Drug Administration Adverse Event Reporting System was queried for reports of myasthenia gravis exacerbations occurring in patients taking fluoroquinolones.Macrolides have a possible association with myasthenia gravis that follows a similar timecourse to the fluoroquinolones.Numerous antipsychotics have been associated with myasthenia gravis exacerbation.A recent retrospective study evaluated the association of myasthenia gravis with low-osmolality contrast agents.Glucocorticoids, although a mainstay in the management of moderate to severe myasthenia gravis, can also cause muscle weakness.A number of reports are available associating immune checkpoint inhibitors such as avelumab, ipilimumab, pembrolizumab, tremelimumab, nivolumab, sintilimab, and atezolizumab with myasthenia gravis. The pathophysiology remains unknown, but generally signs and symptoms begin within 2 to 6 weeks of treatment with these agents.Approximately 1% of patients treated with penicillamine develop autoimmune myasthenia gravis.Although statins are known to cause myotoxicities, myasthenia gravis exacerbations have not been well-reported in the literature.It is possible for a number of medications to contribute to myasthenia gravis. Infections (e.g.
Primary care and emergency room providers are often the first line of care when treating patients with MG and infection. The use of macrolide antibiotics has been reported to exacerbate symptoms of myasthenia gravis and trigger new onset of symptoms of myasthenic syndrome.
Close more info about Guidance for Antibiotic Use in Patients With Myasthenia Gravis Myasthenia gravis patients were twice as often treated with antiepileptic drugs (1.7–2.5). Additional details on some of these medications are provided under the Table.Antimicrobial agents may interact with voltage-gated calcium channels presynaptically, with AChR postsynaptically, or a combination of these mechanisms.Aminoglycosides are associated with myasthenia gravis in numerous case reports typically involving their concomitant use with neuromuscular blockers.Fluoroquinolones have consistently been associated with flares of myasthenia gravis. Obviously, therefore, patients with poorly controlled myasthenia are most at risk from such drugs. pneumonia) can make myasthenia worse (myasthenic crisis). Proper patient education and counseling before starting medications that may affect the neuromuscular junction are essential. When a medication is suspected, it is often withdrawn – at least temporarily.In summary, many drugs have been implicated as a cause of myasthenia gravis or disease exacerbation. As many medications can affect neuromuscular transmission and it may be impractical to avoid use of all of these medications, clinicians should closely monitor patients with MG who are started on new medications.